Neuraxis (NRXS) executive makes small open-market share purchase

Rhea-AI Filing Summary

Neuraxis, INC executive Thomas Joeseph Carrico, who serves as CRO, CCO and CPO, bought 667 shares of the company’s common stock in an open-market purchase at $1.96 per share. Following this transaction, he directly holds a total of 331,903 common shares.

Insider Trade Summary

Net Buyer: 667 shares ($1,307)

Net Buy 1 txn

Insider Carrico Thomas Joeseph

Role CRO, CCO, CPO

Bought 667 shs ($1K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	667	$1.96	$1K

Holdings After Transaction: Common Stock — 331,903 shares (Direct)

Footnotes (1)

Key Figures

Shares purchased: 667 shares Purchase price: $1.96 per share Total shares after transaction: 331,903 shares +1 more

4 metrics

Shares purchased 667 shares Open-market purchase of common stock

Purchase price $1.96 per share Price paid in the April 1, 2026 transaction

Total shares after transaction 331,903 shares Direct ownership following the Form 4 transaction

Buy transactions in filing 1 transaction Form 4 transaction summary buy count

Key Terms

open-market purchase, Common Stock, Form 4

3 terms

open-market purchase financial

"transaction_action: "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carrico Thomas Joeseph

(Last) (First) (Middle)

11611 N. MERIDIAN ST, SUITE 330

(Street)

CARMEL INDIANA 46032

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Neuraxis, INC [ NRXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CRO, CCO, CPO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		P		667	A	$1.96	331,903	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Thomas Carrico	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Neuraxis (NRXS) report in this Form 4?

Neuraxis reported that executive Thomas Joeseph Carrico made an open-market purchase of common stock. He acquired 667 shares at $1.96 per share and now directly owns 331,903 shares following the transaction.

Who at Neuraxis (NRXS) bought shares and what is their role?

Thomas Joeseph Carrico, an executive at Neuraxis serving as CRO, CCO and CPO, bought shares. The filing shows he purchased 667 common shares and now directly holds 331,903 shares of Neuraxis common stock.

How many Neuraxis (NRXS) shares did the insider buy and at what price?

The insider bought 667 shares of Neuraxis common stock in an open-market transaction. The reported purchase price was $1.96 per share, according to the Form 4 insider trading report.

What is the insider’s total Neuraxis (NRXS) shareholding after this trade?

After the reported transaction, the insider directly owns 331,903 Neuraxis common shares. This total includes the 667 shares purchased in the open-market trade disclosed in the Form 4 filing.

Was the Neuraxis (NRXS) insider transaction a buy or a sell?

The Neuraxis insider transaction was a buy. The Form 4 identifies the code as “P” for purchase and describes it as an open-market transaction where the insider acquired 667 common shares at $1.96 each.